About PNEUMA
PNEUMA is a company based in New York (United States) founded in 2022.. PNEUMA has raised $715 thousand across 1 funding round from investors including IndieBio. PNEUMA offers products and services including OXYA and SPIRO. PNEUMA operates in a competitive market with competitors including Checkerspot, Fermbox, Bcomp, Industrial Microbes and altM, among others.
- Headquarter New York, United States
-
Sectors
Chemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pneuma Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$715 K (USD)
in 1 rounds
-
Latest Funding Round
$715 K (USD), Seed
Dec 22, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PNEUMA
PNEUMA offers a comprehensive portfolio of products and services, including OXYA and SPIRO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Material containing living microorganisms for multipurpose applications.
Technology combining bioinspired processes with engineering for material creation.
Unlock access to complete
Unlock access to complete
Funding Insights of PNEUMA
PNEUMA has successfully raised a total of $715K through 1 strategic funding round. The most recent funding activity was a Seed round of $715 thousand completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $715,000
-
First Round
First Round
(22 Dec 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Seed - PNEUMA | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PNEUMA
PNEUMA has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PNEUMA
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PNEUMA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pneuma Comparisons
Competitors of PNEUMA
PNEUMA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Checkerspot, Fermbox, Bcomp, Industrial Microbes and altM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
High-performance materials are developed using synthetic biology for diverse applications.
|
|
| domain | founded_year | HQ Location |
Alternative animal products are developed via microbial precision fermentation.
|
|
| domain | founded_year | HQ Location |
Sustainable biomaterials for lightweighting in automotive and aerospace are provided.
|
|
| domain | founded_year | HQ Location |
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals
|
|
| domain | founded_year | HQ Location |
Engineering agri-waste into purpose
|
|
| domain | founded_year | HQ Location |
Sustainable biopolymers are developed from biomass for industrial uses.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about PNEUMA
When was PNEUMA founded?
PNEUMA was founded in 2022.
Where is PNEUMA located?
PNEUMA is headquartered in New York, United States. It is registered at New York, New York, United States.
Is PNEUMA a funded company?
PNEUMA is a funded company, having raised a total of $715K across 1 funding round to date. The company's 1st funding round was a Seed of $715K, raised on Dec 22, 2022.
What does PNEUMA do?
PNEUMA was founded in 2022 in New York, United States, within the biotechnology and sustainable materials sector. Engineered fabrics are created using advanced processes to produce living textiles that incorporate active photosynthesis and full biodegradability. Biotechnology laboratory solutions are supplied alongside a range of sustainable materials for industrial and research applications. Operations center on innovation in eco-friendly textiles for broader environmental integration.
Who are the top competitors of PNEUMA?
PNEUMA's top competitors include Checkerspot, Bloom Biorenewables and Industrial Microbes.
What products or services does PNEUMA offer?
PNEUMA offers OXYA and SPIRO.
Who are PNEUMA's investors?
PNEUMA has 1 investor. Key investors include IndieBio.